Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
Clinical trial NCT05089370 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05089370
- Sponsor
- University of Colorado, Denver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2026-08-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.